This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Free AAPS Webinar to explore use of PKPD modeling

October 21st, 2009

WHO: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific society of approximately 12,000 members employed in industry, academia, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development.

WHAT: AAPS is pleased to present the complimentary eLearning Webinar on Use of PKPD Modeling for Starting Dose Selection in First-in-Human Trials of Biologics. This module is organized by the AAPS Clinical Pharmacology and Translational Research Section. This Webinar will be conducted by Balaji Agoram, Ph.D.

WHY: The purpose of this free Webinar is to illustrate the use of pharmacokinetic/pharmacodynamic models to select rational starting doses in clinical trials within the Minimum Anticipated Biological Effect Level (MABEL) principle using literature data and through simulations. Participants will gain understanding of the complex biologic drug-receptor interaction dynamics and the multiple factors affecting the dose-receptor occupancy relationship.

WHEN: October 29, 2009

12:30 PM to 2:00 PM EDT

Source: American Association of Pharmaceutical Scientists

Citation: Free AAPS Webinar to explore use of PKPD modeling (2009, October 21) retrieved 23 July 2025 from https://sciencex.com/wire-news/17585547/free-aaps-webinar-to-explore-use-of-pkpd-modeling.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.